▲
STOCKUPSIDE.IO
Analyst Price Target Intelligence
← Full Rankings
← Back to rankings
Ranked #1251 by analyst upside · 2026-11-12
CURLF
Curaleaf Holdings, Inc.
Healthcare · Market Cap $2B · P/E 0x
ANALYST PRICE TARGET
+80.4%
implied upside to consensus target
Current Price $8.87
Consensus Target $16.0
Bull Target $17.0
Bear Target $15.0
Analysts Covering 2
ANALYST CONSENSUS - BUY
Strong Buy
0
Buy
2
Hold
0
Sell
0
52-Week Low $5.4
52-Week High $15.15
YTD Return +12.8%
FUNDAMENTALS
Market Cap $2B
P/E Ratio (TTM) N/A
Forward P/E N/A
EPS (TTM) $-0.05
PEG Ratio N/A
Dividend Yield N/A
Revenue (TTM) $1.4B
Profit Margin -0.8%
52-WEEK RANGE
52-Week Low $5.4
52-Week High $15.15
Current Price $8.87
Bear Target $15.0
Bull Target $17.0
● Now $8.87 ● Target $16.0
TRADING DATA
Avg Volume 207K
YTD Return +12.8%
Analyst Count 2
Consensus Buy
Upside to Target +80.4%
Last Updated 2026-11-12

ANALYST SUMMARY

Curaleaf Holdings, Inc. (CURLF) is currently trading at $8.87 with a Wall Street consensus price target of $16.0, implying potential upside of 80.4% over the next 12 months. 2 analysts currently cover CURLF, with a consensus rating of Buy - 100% of analysts rate the stock a Buy or Strong Buy. The most bullish analyst has a price target of $17.0, while the most cautious has a target of $15.0.

CURLF operates in the Healthcare sector with a market capitalisation of $2B. The stock is up 12.8% year-to-date and is currently trading near the lower end of its 52-week range of $5.4 – $15.15.

SIMILAR STOCKS

Other Healthcare stocks with comparable size and valuation.

RECENT ANALYST CALLS

Upgrade/downgrade history for CURLF, with each firm's 90-day track record across all stocks we track. See full firm rankings →

Needham reit
Buy → Buy 2024-08-08 20% win rate (5 calls)
HISTORICAL SNAPSHOT

Point-in-time data from StockUpside's daily snapshots. Tracks price, analyst target, upside %, consensus, and analyst count.

Loading…
ANALYST CONVICTION SCORE
60
out of 100
Coverage depth
8/30
Consensus clarity
25/30
Vote unanimity
25/25
Rating stability
2/15

Measures analyst agreement, not fundamental quality. A high score means analysts broadly agree on this call - not that the stock will go up.

See 4,000+ stocks ranked by analyst upside

StockUpside.io tracks analyst consensus price targets across thousands of US-listed stocks, updated every day. The full ranked list is available with a Pro subscription.

View Full Rankings →